Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI

Background and Aims: Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. We investigated, in a highly translatable animal m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gemma Vilahur, Pablo Sutelman, Soumaya Ben-Aicha, Guiomar Mendieta, Monika Radiké, Leonie Schoch, Laura Casaní, María Borrell-Pagés, Teresa Padro, Lina Badimon
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Assuntos:
spirulina
STEMI
cardioprotection
antioxidation
anti-inflammatory
anti-apoptotic
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fphar.2022.891801/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares